FMP
NASDAQ
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
4.62 USD
-0.125 (-2.71%)
Mr. Sean McClain
Healthcare
Biotechnology
https://www.absci.com
NASDAQ
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
0001672688
US00091E1091
00091E109
18105 SE Mill Plain Boulevard
360 949 1041
US
155
Jul 22, 2021